Valneva SE, a specialty vaccine company, and Pfizer Inc. announced that they have entered into an Equity Subscription Agreement and have updated the terms...
Valneva SE ,a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...
